Adverse events | High BNP group | Extra-high BNP group | ||||
---|---|---|---|---|---|---|
Dobutamine (n = 30) | rhBNP (n = 28) | P value | Dobutamine (n = 23) | rhBNP (n = 24) | P value | |
Symptomatic hypotension | 0 | 0 | 1.000 | 0 | 1 | 1.000 |
Asymptomatic hypotension | 0 | 2 | 0.229 | 0 | 3 | 0.234 |
Sustained VT | 0 | 0 | 1.000 | 0 | 0 | 1.000 |
Nonsustained VT | 2 | 0 | 0.492 | 2 | 1 | 0.609 |
VF | 0 | 0 | 1.000 | 0 | 0 | 1.000 |
Sudden death | 0 | 0 | 1.000 | 0 | 0 | 1.000 |
Cardiac arrest | 0 | 0 | 1.000 | 0 | 0 | 1.000 |